sandoz-21-009 has been researched along with mesulergine in 1 studies
| Studies (sandoz-21-009) | Trials (sandoz-21-009) | Recent Studies (post-2010) (sandoz-21-009) | Studies (mesulergine) | Trials (mesulergine) | Recent Studies (post-2010) (mesulergine) |
|---|---|---|---|---|---|
| 19 | 0 | 0 | 265 | 10 | 28 |
| Protein | Taxonomy | sandoz-21-009 (IC50) | mesulergine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0019 | |
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | 0.205 | |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 0.0021 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0052 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 0.0021 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beauchamp, RD; Greeley, GH; Ishizuka, J; Thompson, JC; Townsend, CM | 1 |
1 other study(ies) available for sandoz-21-009 and mesulergine
| Article | Year |
|---|---|
Receptor-mediated autocrine growth-stimulatory effect of 5-hydroxytryptamine on cultured human pancreatic carcinoid cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Cell Division; Cyclic AMP; Cyclic GMP; Ergolines; Humans; Pancreatic Neoplasms; Pertussis Toxin; Phosphatidylinositols; Pindolol; Receptors, Serotonin; Second Messenger Systems; Serotonin; Serotonin Antagonists; Tumor Cells, Cultured; Virulence Factors, Bordetella | 1992 |